Trial Profile
Tolerability and effects of rifampicin on the pharmacokinetics of nevirapine and efavirenz, in patients with HIV infections and tuberculosis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Feb 2011
Price :
$35
*
At a glance
- Drugs Efavirenz (Primary) ; Nevirapine (Primary) ; Rifampicin (Primary)
- Indications HIV infections; Tuberculosis
- Focus Adverse reactions; Pharmacokinetics
- 05 Nov 2010 New trial record.